Zerbor / Shutterstock.com
US pharmaceutical company Strategic Science and Technologies (SST) has signed an option agreement with “one of the world’s largest over-the-counter (OTC) healthcare companies” to commercialise one of its ibuprofen products.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Strategic Science and Technologies; FDA; Ibuprofen